EU regulator confirms recommendation to suspend drugs over flawed studies

May 22, 2015 12:15 PM

28 0

The European Medicines Agency confirmed on Friday its recommendation to suspend a number of medicines that were granted EU approval based on clinical studies conducted at Indian firm GVK Biosciences' facility in Hyderabad, India.

The Committee for Medicinal Products for Human Use (CHMP) said a re-examination of the medicines, prompted by a request from marketing authorization holders for seven of the drugs, revealed that concerns about the reliability of the clinical studies remained. (

Read more

To category page